榮豐控股(000668.SZ)擬實現對威宇醫療的控制
格隆匯 11 月 9日丨榮豐控股(000668.SZ)公佈,公司擬採用支付現金的方式購買盛世達持有標的公司安徽威宇醫療器械科技有限公司(曾用名:蕪湖東旭威宇醫療器械科技有限公司)的全部30.15%股權、擬以現金0.60億元對標的公司進行增資,標的公司的其他股東均放棄優先購買權和優先認繳權。此外,長沙文超、新餘納鼎將其持有標的公司的全部45.23%股權的表決權不可撤銷地委託給公司。上述交易實施完成後,公司將實現對標的公司的控制。
標的公司威宇醫療是專業化的醫用骨科植入耗材配送和技術服務提供商,主營脊柱、創傷、關節等醫用骨科植入耗材銷售及配送業務,並提供相關的技術性服務。此次交易完成後,威宇醫療將成為公司控股子公司,公司將迅速切入醫療健康行業,全面深入佈局醫用骨科植入耗材相關領域,並逐步實現醫用骨科植入耗材的生產、配送及技術服務到下游自建骨科醫院的產業鏈覆蓋,實現主營業務的轉型。威宇醫療所在的醫用骨科植入耗材行業前景良好,空間廣闊,極具市場潛力。此次交易有利於公司業務轉型,培育新的利潤增長點,公司的盈利能力及發展空間將得到有效提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.